Zelvina 10 mg hard capsules, Zelvina 25 mg hard capsules, MINJUVI 200 mg powder for concentrate for solution for infusion, Zelvina 5 mg hard capsules
MOR208C115
Phase 2 small_molecule active
Quick answer
Zelvina 10 mg hard capsules, Zelvina 25 mg hard capsules, MINJUVI 200 mg powder for concentrate for solution for infusion, Zelvina 5 mg hard capsules for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) is a Phase 2 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active